The CIP+ LS-LNPs treated group revealed no significant differences in the blood serum levels of IFN-γ and TNF-α when compared with the NC group in both 7- and 14-days post-challenge (Table 2). The gene discussed is TNF; the disease is hereditary sensory and autonomic neuropathy.